Kinevant Sciences GmbH
- Address
- Viaduktstrasse 8
Sponsor Overview
Specializations
Respiratory Inflammation and Lung Disease
Clinical research is centered on chronic pulmonary sarcoidosis, with a focus on inflammatory disease affecting the lungs and the clinical burden of worsening respiratory symptoms.
- Chronic pulmonary sarcoidosis
- Lung inflammatory disease
- Respiratory inflammation
The sponsor’s research interest lies in therapies aimed at controlling pulmonary inflammation and reducing the need for rescue treatment in patients with active disease.
Immunology and Inflammatory Pathways
The trial portfolio reflects interest in immune-mediated mechanisms involved in sarcoidosis, particularly pathways that contribute to persistent inflammation in the respiratory tract.
- Immune-mediated disease
- Inflammatory pathways
- Pulmonary immune dysfunction
Research activity in this area is directed toward modulating inflammation associated with progressive lung involvement.
Therapeutic Development in Biologic Medicine
The sponsor’s clinical work includes evaluation of namilumab in a respiratory inflammatory setting, indicating a therapeutic interest in biologic approaches for immune-driven lung disorders.
- Namilumab
- Biologic therapy
- Immune-targeted treatment
This area of activity is focused on treatment options for patients with sarcoidosis-related pulmonary inflammation.
Clinical Care for Worsening Sarcoidosis
Research attention extends to clinical management of exacerbations in sarcoidosis, including the need for additional intervention when respiratory disease becomes more severe.
- Rescue treatment
- Disease worsening
- Patient management
These interests align with care for patients experiencing active pulmonary symptoms and inflammatory flare-ups.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of Namilumab in Patients with Chronic Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study |  Belgium France Germany The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 11 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
Partnered Research Centres
11 centres- Address
- Avenue De L'Hopital 1, 4000 Liège
- Address
- Rue Michel Polonovski, 59037 Lille
- Address
- Hippokrateslaan 10, Batiment 54, 1200 Woluwe-Saint-Lambert
- Address
- Dr. Molewaterplein 40, 3015 GD Rotterdam
- Address
- Walterhoeferstrasse 11, Zehlendorf, 14165 Berlin
- Address
- 46 Rue Henri Huchard, cedex Paris 18, 75877 Paris
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Kinevant Sciences GmbH.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.